PBK and lung adenocarcinoma: Notably, miR-216b downregulates TOPK by binding to its 3' untranslated region (3' UTR) 147, whereas miR-216b-3p suppresses lung adenocarcinoma cell proliferation by targeting TOPK, leading to increased p53 and p21 expression and inhibition p38 MAPK activation 192.